Early Lifestyle Interventions in People with Impaired Glucose Tolerance in Northern Colombia: The DEMOJUAN Project.

Noël C Barengo, Tania Acosta, Astrid Arrieta, Carlos Ricaurte, Dins Smits, Karen Florez, Jaakko O Tuomilehto

Journal: International journal of environmental research and public health 2019;16(8):1403

PMID: 31003515

Abstract

BACKGROUND

The objective of the demonstration project for type 2 diabetes prevention in the Barranquilla and Juan Mina (DEMOJUAN) study was to investigate the extent to which it is possible to reach normal glucose metabolism with early lifestyle interventions in people at high risk of type 2 diabetes (prediabetes), compared with those who receive standard usual care.

METHODS

DEMOJUAN was a randomized controlled trial conducted in Juan Mina and Barranquilla, Northern Colombia. Eligible participants were randomized into one of three groups (control group, initial nutritional intervention, and initial physical activity intervention). The duration of the intervention was 24 months. The main study outcome in the present analysis was reversion to normoglycemia. Relative risks and their corresponding 95% confidence intervals were calculated for reversal to normoglycemia and T2D incidence.

RESULTS

There was no statistically significant association between the intervention groups and reversion to normoglycemia. The relative risk of reversion to normoglycemia was 0.88 (95% CI 0.70-1.12) for the initial nutritional intervention group participants and 0.95 (95% CI 0.75-1.20) for the initial physical activity intervention group participants.

CONCLUSIONS

Our study did not find any statistically significant differences in reversion to normoglycemia or the development of type 2 diabetes between the intervention groups and the control group in this population.

Address: Department of Medical and Population Health Research, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33178, USA. [email protected].; Department of Public Health, Faculty of Medicine, University of Helsinki, 00100 Helsinki, Finland. [email protected].; Department of Public Health, Universidad del Norte, Barranquilla 080001, Colombia. [email protected].; Centro de Investigation Sanitaria, Barranquilla 080001, Colombia. [email protected].; Centro de Investigation Sanitaria, Barranquilla 080001, Colombia. [email protected].; Faculty of Medicine, Riga Stradins University, LV-1007 Riga, Latvia. [email protected].; Departamento de Matemáticas y Estadística, Universidad del Norte, Barranquilla 080001, Colombia. [email protected].; Department of Public Health, Faculty of Medicine, University of Helsinki, 00100 Helsinki, Finland. [email protected].; Department of Public Health Solutions, National Institute for Health and Welfare, 00271 Helsinki, Finland. [email protected].; Saudi Diabetes Research Group, King Abdulaziz University, Jeddah 21589, Saudi Arabia. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.